Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for CRVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 25.99M
March 31, 2026 15.11M
December 31, 2025 23.40M
September 30, 2025 30.61M
June 30, 2025 38.08M
March 31, 2025 38.58M
December 31, 2024 43.46M
September 30, 2024 48.88M
June 30, 2024 53.19M
March 31, 2024 7.997M
December 31, 2023 9.972M
September 30, 2023 12.04M
June 30, 2023 15.69M
March 31, 2023 18.40M
December 31, 2022 4.158M
September 30, 2022 26.32M
June 30, 2022 29.18M
March 31, 2022 33.57M
December 31, 2021 37.84M
September 30, 2021 40.88M
June 30, 2021 52.71M
March 31, 2021 56.21M
December 31, 2020 29.55M
September 30, 2020 31.92M
June 30, 2020 35.99M
Date Value
March 31, 2020 21.06M
December 31, 2019 24.28M
September 30, 2019 16.20M
June 30, 2019 18.93M
March 31, 2019 15.99M
December 31, 2018 18.64M
September 30, 2018 23.59M
June 30, 2018 29.94M
March 31, 2018 33.37M
December 31, 2017 26.15M
September 30, 2017 28.33M
June 30, 2017 33.91M
March 31, 2017 36.34M
December 31, 2016 17.48M
September 30, 2016 19.05M
June 30, 2016 19.92M
March 31, 2016 22.91M
December 31, 2015 19.92M
September 30, 2015 23.38M
June 30, 2015 36.65M
March 31, 2015 39.62M
December 31, 2014 42.78M
September 30, 2014 50.55M
June 30, 2014 54.53M
March 31, 2014 26.45M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics